USE OF TRANSFERRED NUCLEAR-OVERHAUSER-EFFECT SPECTROSCOPY TO MEASURE THE BOUND CONFORMATION OF A DISULFIDE-REPLACED ANALOG OF GLUTATHIONE DISULFIDE AS AN INHIBITOR OF YEAST GLUTATHIONE-REDUCTASE

Citation
Kj. Embrey et al., USE OF TRANSFERRED NUCLEAR-OVERHAUSER-EFFECT SPECTROSCOPY TO MEASURE THE BOUND CONFORMATION OF A DISULFIDE-REPLACED ANALOG OF GLUTATHIONE DISULFIDE AS AN INHIBITOR OF YEAST GLUTATHIONE-REDUCTASE, European journal of biochemistry, 221(2), 1994, pp. 793-799
Citations number
17
Categorie Soggetti
Biology
ISSN journal
00142956
Volume
221
Issue
2
Year of publication
1994
Pages
793 - 799
Database
ISI
SICI code
0014-2956(1994)221:2<793:UOTNST>2.0.ZU;2-9
Abstract
The analogue of glutathione disulphide (GSSG) in which the disulphide bridge of GSSG is replaced by -CH2-S- was synthesised from L-cystathio nine using t-butoxycarbonyl and t-butyl ester protection with triethyl silane-promoted deprotection. This analogue (GCSG) was found to be a l inear, competitive inhibitor of yeast glutathione reductase (K-i value 981 mu M at pH 7.0), a very poor substrate and not to act as an irrev ersible inhibitor of glutathione reductase. The weak binding of GCSG t o glutathione reductase permitted the use of transferred nuclear Overh auser effect spectroscopy (TRNOESY) to investigate the bound conformat ion of GCSG in its complex with glutathione reductase. The solution st ructure of free GCSG was investigated by NMR spectroscopy using a rang e of NMR techniques. The TRNOESY experiment allowed a range of conform ations to be determined for the central bridge region (containing the -CH2-S- replacement) of GCSG bound to yeast glutathione reductase. Usi ng the nuclear Overhauser effect constraints thus derived, in combinat ion with molecular graphics and energy minimisation based on the known crystal coordinates of glutathione disulphide (GSSG) bound to human e rythrocyte glutathione reductase, allowed an explanation of the lack o f substrate activity of GCSG, its inactivity as a suicide inactivator and its relatively weak binding in terms of the enforced mislocation o f the -CH2-S- bridge with respect to the catalytic residues (relative to GSSG). Thus, the simple replacement of -S- by -CH2-, common in medi cinal chemistry, can lead to poor receptor binding if the replacement occurs in a central, rather than peripheral, part of the ligand under modification.